Integra LifeSciences Holdings Total Assets
Integra LifeSciences Holdings total assets. Based on the latest financial reports, Integra LifeSciences Holdings (IART) holds total assets worth $3.58 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Integra LifeSciences Holdings (IART) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Integra LifeSciences Holdings (1995–2025)
Total assets of Integra LifeSciences Holdings from 1995 to 2025. This chart illustrates how Integra LifeSciences Holdings's total assets have evolved over time, based on quarterly financial data. See IART live share price for real-time trading data and today's change.
Integra LifeSciences Holdings - Asset Composition Analysis
Integra LifeSciences Holdings Total Assets Breakdown (December 2025)
Integra LifeSciences Holdings total assets breakdown as of December 2025. Integra LifeSciences Holdings's total assets of $3.58 Billion consist of 32.2% current assets and 67.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.5% |
| Accounts Receivable | $278.85 Million | 7.7% |
| Inventory | $492.74 Million | 13.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.13 Billion | 31.5% |
| Goodwill | $615.16 Million | 17.1% |
Asset Composition Trend (1995–2025)
This chart illustrates how Integra LifeSciences Holdings's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Integra LifeSciences Holdings to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Integra LifeSciences Holdings's current assets represent 32.2% of total assets in 2025, a decrease from 47.9% in 1995.
- Cash Position: Cash and equivalents constituted 6.5% of total assets in 2025, down from 23.2% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 0.0% in 1995.
- Asset Diversification: The largest asset category is intangible assets at 31.5% of total assets.
Integra LifeSciences Holdings Competitors by Total Assets
Key competitors of Integra LifeSciences Holdings based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Integra LifeSciences Holdings - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.38 | 1.06 | 3.24 |
| Quick Ratio | 1.95 | 0.57 | 2.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $825.17 Million | $52.71 Million | $713.63 Million |
Integra LifeSciences Holdings - Advanced Valuation Insights
This section examines the relationship between Integra LifeSciences Holdings's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.27 |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | -10.8% |
| Total Assets | $3.60 Billion |
| Market Capitalization | $1.06 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Integra LifeSciences Holdings's assets below their book value (0.29x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Integra LifeSciences Holdings's assets decreased by 10.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Integra LifeSciences Holdings (1995–2025)
The table below shows the annual total assets of Integra LifeSciences Holdings from 1995 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $3.60 Billion | -10.78% |
| 2024-12-31 | $4.04 Billion | +6.75% |
| 2023-12-31 | $3.78 Billion | -2.77% |
| 2022-12-31 | $3.89 Billion | +2.84% |
| 2021-12-31 | $3.78 Billion | +4.63% |
| 2020-12-31 | $3.62 Billion | +9.44% |
| 2019-12-31 | $3.30 Billion | +6.29% |
| 2018-12-31 | $3.11 Billion | -3.22% |
| 2017-12-31 | $3.21 Billion | +77.62% |
| 2016-12-31 | $1.81 Billion | +1.87% |
| 2015-12-31 | $1.77 Billion | +12.42% |
| 2014-12-31 | $1.58 Billion | +31.97% |
| 2013-12-31 | $1.20 Billion | +2.80% |
| 2012-12-31 | $1.16 Billion | +1.70% |
| 2011-12-31 | $1.14 Billion | +12.46% |
| 2010-12-31 | $1.02 Billion | +8.21% |
| 2009-12-31 | $940.10 Million | -9.12% |
| 2008-12-31 | $1.03 Billion | +26.46% |
| 2007-12-31 | $818.01 Million | +33.31% |
| 2006-12-31 | $613.62 Million | +36.84% |
| 2005-12-31 | $448.43 Million | -1.81% |
| 2004-12-31 | $456.71 Million | +10.71% |
| 2003-12-31 | $412.53 Million | +50.19% |
| 2002-12-31 | $274.67 Million | +20.69% |
| 2001-12-31 | $227.59 Million | +163.06% |
| 2000-12-31 | $86.51 Million | +30.49% |
| 1999-12-31 | $66.30 Million | +91.07% |
| 1998-12-31 | $34.70 Million | -9.64% |
| 1997-12-31 | $38.40 Million | -21.15% |
| 1996-12-31 | $48.70 Million | +151.03% |
| 1995-12-31 | $19.40 Million | -- |
About Integra LifeSciences Holdings
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural … Read more